Friday, August 21, 2026
GlobeNewsInfo Logo
Home / Business & Corporate / Middle East Pharmaceutical Industries secures SAR 60 million working capital facility from SIDF

Middle East Pharmaceutical Industries secures SAR 60 million working capital facility from SIDF

Published on
Middle East Pharmaceutical Industries secures SAR 60 million working capital facility from SIDF
Image used for illustrative purposes only. GlobeNewsInfo / Visuals

Middle East Pharmaceutical Industries Co. has entered into a two-year SAR 60 million financing agreement with the Saudi Industrial Development Fund (SIDF) to support its working capital requirements. The facility is secured against previously pledged industrial assets and land, alongside a promissory note, strengthening the company's access to operational funding.

SAUDI ARABIA —Middle East Pharmaceutical Industries Co. has secured a SAR 60 million working capital financing facility from the Saudi Industrial Development Fund (SIDF), under an agreement signed on 8 November 2026. The funding will be available for a period of two years from the date of receipt and is intended to support the pharmaceutical manufacturer's day-to-day operating requirements, including the financing of its working capital cycle.

The financing arrangement uses existing security over the company's fixed assets and land at the Avalon-2 facility and Central Warehouse. These properties had previously been pledged to SIDF in connection with an existing medium-term loan and will also serve as collateral for the new facility. In addition, the company has provided a promissory note covering the full financing amount of SAR 60 million. No related parties are involved in the transaction.

Access to working capital is particularly important for pharmaceutical manufacturers, whose operations require continuous procurement of active pharmaceutical ingredients, packaging materials and other production inputs. Funding availability also supports inventory management, manufacturing continuity and the management of payment cycles involving distributors, healthcare providers and other customers. The new facility therefore provides Middle East Pharmaceutical Industries with additional financial resources to manage routine operational commitments over the financing period.

Middle East Pharmaceutical Industries operates in Saudi Arabia's pharmaceutical manufacturing sector, producing medicines for the domestic healthcare market. The Saudi Industrial Development Fund (SIDF) is a government-backed development financing institution that provides financial support to industrial activities and contributes to the expansion of the Kingdom's manufacturing base.

The agreement also illustrates the role of specialised development financing in supporting the operational requirements of Saudi Arabia's pharmaceutical industry. Domestic manufacturers require dependable access to financing to maintain production capacity, manage supply-chain requirements and respond to demand from the healthcare sector. Working capital facilities can help address short-term liquidity requirements without relying exclusively on internally generated cash flows.

For Middle East Pharmaceutical Industries, the two-year facility offers additional liquidity while extending the use of assets already pledged under its existing borrowing arrangements. However, the reuse of collateral means that the company's secured asset base remains linked to multiple financing obligations with the same lender. For investors and other stakeholders, the arrangement highlights the importance of monitoring working capital efficiency, borrowing commitments and the company's ability to generate sufficient operating cash flow to meet its financial obligations.

About GlobeNewsInfo

GlobeNewsInfo is a business news platform providing latest updates on global business developments, projects, and contract opportunities across diverse sectors and regions. The platform is designed to serve as a trusted source of information for companies, investors, and professionals worldwide.

More on Business & Corporate

Latest Business News

Share this Article

Just In
Yesterday Greece clears final RRF milestones to unlock EUR 11.32 billion in EU funds Yesterday Vietnam overhauls land acquisition framework to accelerate infrastructure and industrial investments Yesterday Deshraj Solar Energy expands northern grid capacity with 147 MW Rajasthan plant Yesterday Slovenia clears final RRF hurdle as EU approves €271.8 million tranche